Publication:
Expression of Plakophilins (PKP1, PKP2, and PKP3) in Breast Cancers

dc.authorscopusid36702709300
dc.authorscopusid22945639700
dc.authorscopusid7003323947
dc.authorwosidSullu, Yurdanur/Agl-4996-2022
dc.contributor.authorDemirag, Guzin Gonullu
dc.contributor.authorSullu, Yurdanur
dc.contributor.authorYucel, Idris
dc.contributor.authorIDSullu, Yurdanur/0000-0002-8029-2490
dc.date.accessioned2025-12-11T01:09:24Z
dc.date.issued2012
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Demirag, Guzin Gonullu; Yucel, Idris] Ondokuz Mayis Univ, Fac Med, Dept Med Oncol, TR-55139 Kurupelit, Samsun, Turkey; [Sullu, Yurdanur] Ondokuz Mayis Univ, Fac Med, Dept Pathol, TR-55139 Kurupelit, Samsun, Turkeyen_US
dc.descriptionSullu, Yurdanur/0000-0002-8029-2490en_US
dc.description.abstractPlakophilins (PKP) are desmosomal plague proteins, which belong to the p120ctn subfamily of armadillo repeat containing proteins. We aimed to analyze the role of plakophilins in breast cancer and its clinical progress. We have performed immunohistochemical study of the PKP1,2,3 in breast carcinoma. The study included 108 patients with breast cancer and 26 age-and sex-matched healthy controls. We investigated the associations between staining intensity and some clinicopathologic features like tumor size, axillary node status, stage, lymphovascular invasion, perineural invasion, grade, hormone receptor status, and c-erb B2. The mean age of patients was 46 years (22-78). In breast cancer, compared with normal tissue, PKP1 and PKP2 expressions were indifferent (P > 0.05), but PKP3 expression was significantly increased in breast cancer (P = 0.0014). Although PKP1 and PKP2 expression levels were not correlated with clinicopathological parameters, increased PKP3 expression was positively correlated with node positivity and grade (P = 0.000, P = 0.000). Conclusion: Overexpressed PKP3 is likely to be an essential contributor to a growth-promoting pathway and to aggressive features of breast cancer.en_US
dc.description.woscitationindexScience Citation Index Expanded
dc.identifier.doi10.1007/s12032-011-0071-1
dc.identifier.endpage1522en_US
dc.identifier.issn1357-0560
dc.identifier.issue3en_US
dc.identifier.pmid21947748.0
dc.identifier.scopus2-s2.0-84872790135
dc.identifier.scopusqualityQ3
dc.identifier.startpage1518en_US
dc.identifier.urihttps://doi.org/10.1007/s12032-011-0071-1
dc.identifier.urihttps://hdl.handle.net/20.500.12712/41700
dc.identifier.volume29en_US
dc.identifier.wosWOS:000307964100018
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherHumana Press Incen_US
dc.relation.ispartofMedical Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectBreasten_US
dc.subjectImmunohistochemistryen_US
dc.subjectPlakophilinen_US
dc.titleExpression of Plakophilins (PKP1, PKP2, and PKP3) in Breast Cancersen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files